Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 |Industry: Pharmaceuticals
|Expensive Performer
647.15 1.55 (0.24%)
NSE Mar 20, 2019 15:31
Volume: 624.3K
 
Durability score
65 /100
High Financial Strength
Valuation score
30 /100
Expensive Valuation
Momentum score
57.4 /100
Neutral Momentum
Market Capitalizati...
18,260.6 Cr.
High in industry
AVG Broker Target
655.8
1.34% upside
PE TTM Price to Ear...
20.0
Above industry median.
Fetching latest news from server
Poll
VOTE: What's your call on Glenmark Pharmaceuticals Limited?
Total Votes: 95
BUY
SELL
HOLD
82.11%
12.63%
5.26%
  • Stock Price (632.75) crossed above 200 Day SMA (618.08) on 12 March, 2019
  • Stock Price (600.0) crossed below 30 Day SMA (611.15) on 08 March, 2019
  • IDBI Capital released a Accumulate report for Glenmark Pharmaceuticals Ltd. with a price target of 654.0 on 18 Feb, 2019.
  • Day volume (4210524.0) was 597% of the Month Average Volume (705253.0) on 15 February, 2019
  • Stock Price (613.5) crossed below 150 Day SMA (632.17) on 08 February, 2019
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 19, 20182.00FINAL-
Sept. 20, 20172.00FINAL-
Aug. 3, 20162.00FINAL-
Sept. 10, 20152.00FINAL-
July 10, 20142.00FINAL-
All dividends by GLENMARK
Ex-Date Dividend Bonus Ratio Record Date
March 4, 20051:1-
All bonuses by GLENMARK
Ex-Date Dividend Old FVNew FV Record Date
Sept. 10, 200721-
Oct. 23, 2003102Oct. 31, 2003
All splits by GLENMARK